Stryker

Stryker Corp. (NYSE:SYK) has agreed acquire Concentric Medical Inc. for $135 million in cash in a deal expected to close by the end of the year.

Stryker Corporation has appointed Ramesh Subrahmanian as Group President of its international business.

Corin PLC to Resume Direct Distribution of Cormet Hip Resurfacing System as Stryker ends distribution agreement.

Stryker Corporation announced today a definitive agreement to acquire Orthovita, Inc. (Nasdaq:VITA), a global developer and manufacturer of orthobiologic and biosurgery products through an all cash tender offer.

Stryker and Intuitive Surgical sign an agreement to integrate both companies’ technologies into advanced minimally invasive (MIS) robotic surgery suites.

Stryker Corporation announces senior level organizational changes, effective today.

Stryker Corp. has received a subpoena from the Attorney General of New Jersey related to an investigation of financial relationships between companies that make medical products and surgeons that use them.

Stryker Corp. won’t achieve a ninth straight year of double-digit sales growth this year, the company’s chief executive officer told Stryker shareholders Wednesday.

Stryker Corp’s bone-growth putty for spinal surgery should not be approved for expanded use in a wider population, advisors to federal drug regulators said on Tuesday.

Medical device maker Stryker Corp said on Tuesday that it is a target of a federal grand jury probe related to the illegal promotion of human bone growth products and other issues.

WASHINGTON, Dec 30 (Reuters) – A U.S. appeals court upheld an order on Tuesday barring medical device maker Stryker Corp (SYK.N) from selling a screw to fix broken bones because it infringes a patent held by Acumed LLC

The U.S. Justice Department is investigating whether Stryker Corp., the third-largest maker of artificial hips and knees, illegally paid surgeons to induce them to use company products, according to a court filing.